TGFB1 and Duchenne muscular dystrophy: The resulting double-mutant mouse (DMM) showed a reduction in the severity of fibrosis, increased strength, and reduced amounts of transforming growth factor β (TGFβ), which is a well-known driver of fibrosis in the later phases of DMD pathology [35].